Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
5.99
-0.02 (-0.33%)
Apr 29, 2025, 4:00 PM EDT - Market closed
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $227.84 million as of April 30, 2025. Its market cap has decreased by -19.05% in one year.
Market Cap
227.84M
Enterprise Value
156.13M
1-Year Change
-19.05%
Ranking
Category
Stock Price
$5.99
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $227.84M, a decrease of -54.98%. That is a compound annual growth rate of -17.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2025 | 227.84M | -28.81% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |